Search

everythinglearnresearchcommunity

for

Search:↓

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

New diabetes tech and therapies improve care for endocrine disorders.

Live imaging has advanced our understanding of stem cell behavior and raised new research questions.

CD201+ fascia progenitors are essential for wound healing and could be targeted for treating skin conditions.

Biological therapy boosts the immune system to effectively fight melanoma.

Liver stem cells keep their basic functions even in inflamed liver tissue.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Long scalp hair evolved for cooling and social signaling.

The method creates skin organoids with hair follicles for research on skin conditions and treatments.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Blocking interferon-gamma might help treat various autoimmune diseases.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.